Beata Matyjaszek-Matuszek
Overview
Explore the profile of Beata Matyjaszek-Matuszek including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
281
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Golacki J, Matuszek M, Matyjaszek-Matuszek B
Diagnostics (Basel)
. 2022 Jul;
12(7).
PMID: 35885586
Insulin resistance (IR) has become a common health issue in medical practice. There are no detailed data on IR prevalence, but it is an increasing problem due to its close...
12.
Szmygin H, Szydelko J, Matyjaszek-Matuszek B
J Clin Med
. 2022 Jun;
11(11).
PMID: 35683457
Objective: Prolactinomas are the most common type of functional, hormone-secreting pituitary adenomas that account for about 40% of total pituitary adenomas. Typical clinical presentations include loss of menstrual periods (amenorrhea)...
13.
Aravind S, Singh K, Mogylnytska L, Zalevskaya A, Matyjaszek-Matuszek B, Wernicke-Panten K, et al.
Diabetes Ther
. 2022 Jun;
13(7):1299-1310.
PMID: 35650350
Introduction: We compared the efficacy, safety, and immunogenicity of biosimilar insulin aspart premix SAR341402 Mix 70/30 (70% intermediate SAR341402 protamine and 30% rapid SAR341402 solution) (SAR-Mix) with its originator NovoMix...
14.
Aravind S, Singh K, Aquitania G, Mogylnytska L, Zalevskaya A, Matyjaszek-Matuszek B, et al.
Diabetes Ther
. 2022 Apr;
13(5):1053-1071.
PMID: 35420397
Introduction: This study compared the efficacy, safety, and immunogenicity of biosimilar insulin aspart premix SAR341402 Mix 70/30 (SAR-Mix) with European-approved insulin aspart mix 70/30 - NovoMix® 30 (NN-Mix) in people...
15.
Dadej D, Skraba K, Matyjaszek-Matuszek B, Swirska J, Ruchala M, Ziemnicka K
Endokrynol Pol
. 2021 Dec;
72(5):505-511.
PMID: 34855191
Introduction: Rathke cleft cysts (RCC) arise as developmental abnormalities of the pituitary gland and are usually diagnosed incidentally. However, they may present with headaches, visual impairment, or pituitary dysfunction. Rathke...
16.
Szydelko J, Szydelko-Gorzkowicz M, Matyjaszek-Matuszek B
J Clin Med
. 2021 Sep;
10(17).
PMID: 34501445
Acromegaly is a rare disease caused by overproduction of growth hormone (GH) by a pituitary adenoma, and consequently increased insulin-like growth factor 1 (IGF-1) concentration. The GH/IGF-1 axis and immune...
17.
Szmygin H, Szydelko J, Matyjaszek-Matuszek B
Endokrynol Pol
. 2021 Aug;
72(5):566-571.
PMID: 34378786
Arginine vasopressin (AVP), which is also called antidiuretic hormone (ADH), is a neurohormone synthetized from a pre-pro-hormone precursor in the supraoptic and paraventricular nuclei of the hypothalamus in response to...
18.
Czarnywojtek A, Ochmanska A, Zgorzalewicz-Stachowiak M, Sawicka-Gutaj N, Matyjaszek-Matuszek B, Wozniak M, et al.
Adv Clin Exp Med
. 2021 Jul;
30(7):747-755.
PMID: 34286519
The paper summarizes the current knowledge about the influence of SARS-CoV-2 on the thyroid gland and benign thyroid diseases, with emphasis on the situation in Poland. Based on the latest...
19.
Matyjaszek-Matuszek B, Wozniak M, Ochmanska A, Sawicka-Gutaj N, Ruchala M, Czarnywojtek A
Endokrynol Pol
. 2021 May;
72(2):170-178.
PMID: 33970482
On March 11, 2020, the World Health Organisation (WHO) observed the scale of epidemic risk and declared the state of the COVID-19 pandemic. Most countries, including Poland, implemented national and...
20.
Szydelko J, Litwinczuk M, Szydelko M, Matyjaszek-Matuszek B
J Clin Med
. 2020 Sep;
9(10).
PMID: 32993174
Graves' orbitopathy (GO) is an autoimmune disease with a chronic inflammatory background. Smoking behavior is the main environmental factor responsible for the transition of this major extra thyroidal manifestation of...